US Tech 100

20,332.80

1.61%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

AIM AIM ImmunoTech Inc

0.1207

-0.0072 (-5.63%)

Feb 28 2025 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more AIM ImmunoTech Charts.

AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
From Mar 2024 to Mar 2025

AIM ImmunoTech Inc News

Form PRE 14A - Other preliminary proxy statements
Friday 28 February 2025 (2 days ago) • Edgar (US Regulatory)

AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza
Friday 28 February 2025 (2 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 28 February 2025 (2 days ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 26 February 2025 (4 days ago) • Edgar (US Regulatory)

AIM ImmunoTech Announces NYSE American Acceptance of Plan to Regain Listing Compliance
Wednesday 26 February 2025 (4 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 26 February 2025 (4 days ago) • Edgar (US Regulatory)

AIM ImmunoTech Appoints David Chemerow to Board of Directors as an Independent Director
Wednesday 26 February 2025 (4 days ago) • GlobeNewswire Inc.

AIM Doses First New Subject in Phase 2 Study of Ampligen and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic Cancer
Tuesday 25 February 2025 (5 days ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 11 February 2025 (3 weeks ago) • Edgar (US Regulatory)

AIM ImmunoTech Releases Virtual Investor “What This Means Segment”
Tuesday 11 February 2025 (3 weeks ago) • GlobeNewswire Inc.

More AIM ImmunoTech Inc News Articles

RespireRx Pharmaceuticals (CE)

Good Vibrations Shoes (PK)

USOTC

ELTP

Elite Pharmaceuticals (QB)

USOTC

NBRI

North Bay Resources (PK)

Digital Brand Media and ... (PK)

USOTC

NWBO

Northwest Biotherapeutics (QB)

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

AIM AIM ImmunoTech Inc

AIM ImmunoTech Inc News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

AIM AIM ImmunoTech Inc

AIM ImmunoTech Inc News

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free